Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Working Knowledge
Business Research for Business Leaders
  • Browse All Articles
  • Popular Articles
  • Cold Call Podcast
  • Managing the Future of Work Podcast
  • About Us
  • Book
  • Leadership
  • Marketing
  • Finance
  • Management
  • Entrepreneurship
  • All Topics...
  • Topics
    • COVID-19
    • Entrepreneurship
    • Finance
    • Gender
    • Globalization
    • Leadership
    • Management
    • Negotiation
    • Social Enterprise
    • Strategy
  • Sections
    • Book
    • Podcasts
    • HBS Case
    • In Practice
    • Lessons from the Classroom
    • Op-Ed
    • Research & Ideas
    • Research Event
    • Sharpening Your Skills
    • What Do You Think?
    • Working Paper Summaries
  • Browse All
    What Can Economics Say About Alzheimer's Disease?
    28 Sep 2020Working Paper Summaries

    What Can Economics Say About Alzheimer's Disease?

    by Amitabh Chandra, Courtney Coile, and Corina Mommaerts
    This essay discusses the role of market frictions and "missing medicines" in drug innovation and highlights how frameworks and toolkits of economists can help our understanding of the determinants and effects of Alzheimer's disease on health.
    LinkedIn
    Email

    Author Abstract

    Alzheimer’s disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the "economics of Alzheimer’s disease" is an emphasis on cognitive decline, choice by cognitively impaired patients, and a host of issues where dynamic contracts between patients and caregivers are hard to enforce. The presence of cognitively challenged consumers also opens up new areas of study at the intersection of law and economics for it is not clear if firms will exploit these individuals or whether competitive forces will temper the behavior of firms. In addition, the issue of innovation--in prevention, delivery and medicines—is is amplified in the economics of AD, where there may be insufficient investments in basic science and where a fragmented insurance system (at least in the United States) discourages private investments in these innovations. We discuss the role of market frictions and "missing medicines" in drug innovation and highlight how frameworks and toolkits of economists can help in our understanding of the determinants and effects of AD on health.

    Paper Information

    • Full Working Paper Text
    • Working Paper Publication Date: August 2020
    • HBS Working Paper Number: NBER Working Paper Series, No. 27760
    • Faculty Unit(s): Technology and Operations Management
      Trending
        • 16 Mar 2023
        • Research & Ideas

        Why Business Travel Still Matters in a Zoom World

        • 04 Sep 2001
        • Research & Ideas

        Is Government Just Stupid? How Bad Decisions Are Made

        • 25 Jan 2022
        • Research & Ideas

        More Proof That Money Can Buy Happiness (or a Life with Less Stress)

        • 25 Feb 2019
        • Research & Ideas

        How Gender Stereotypes Kill a Woman’s Self-Confidence

        • 14 Mar 2023
        • In Practice

        What Does the Failure of Silicon Valley Bank Say About the State of Finance?

    Amitabh Chandra
    Amitabh Chandra
    Henry and Allison McCance Family Professor of Business Administration
    Contact
    Send an email
    → More Articles
    Find Related Articles
    • Technological Innovation
    • Research
    • Consumer Behavior
    • Health
    • Pharmaceutical

    Sign up for our weekly newsletter

    Interested in improving your business? Learn about fresh research and ideas from Harvard Business School faculty.
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    ǁ
    Campus Map
    Harvard Business School Working Knowledge
    Baker Library | Bloomberg Center
    Soldiers Field
    Boston, MA 02163
    Email: Editor-in-Chief
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College